Dynamics of HPV vaccination initiation in Flanders (Belgium) 2007-2009: A Cox regression model

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Lefevere, Eva ^a,b   Hens, Niel ^a,c   De Smet, Frank ^d,e   Van Damme, Pierre ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b RESEARCH FOUNDATION FLANDERS FWO   (Belgium)

^c HASSELT UNIVERSITY   (Belgium)

^d National Alliance of Christian Mutualities   (Belgium)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; BELGIUM; CHILD; FEMALE; HUMAN; PAPILLOMAVIRUS INFECTION; PREVENTIVE HEALTH SERVICE; PROPORTIONAL HAZARDS MODEL; UTILIZATION REVIEW;

ADOLESCENT; BELGIUM; CHILD; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PROPORTIONAL HAZARDS MODELS;

EID: 79958295684     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-470     Document Type: Article

References (28)

1. Vaccinatie tegen infecties veroorzaakt door het Humaan papillomavirus. http://www.health.belgium.be/eportal/Aboutus/relatedinstitutions/ SuperiorHealthCouncil/publications/factsheetsvaccination/index.htm
2. Health care reform in Belgium. E Schokkaert C Van de Voorde, Health Economics 2005 14 25 S39 10.1002/hec.1027 16161192 (Pubitemid 41404317)
3. Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008. C Simoens M Sabbe P Van Damme P Beutels M Arbyn, Eurosurveillance 2009 14 46 21 24 19317970
4. Out-of-pocket costs of childhood immunizations: a comparison by type of insurance plan. NA Molinari M Kolasa M Messonnier R Schieber, Pediatrics 2007 120 5 1148 1156 10.1542/peds.2006-3654 (Pubitemid 350085509)
5. Behavioral economics and marketing in aid of decision-making among the poor. M Bertrand S Mullainathan E Shafir, Journal of Public Policy and Marketing 2006 25 1 8 23 10.1509/jppm.25.1.8 (Pubitemid 43935641)
6. TM Therneau PM Grambsch, Modeling survival data. Extending the Cox model New York: Springer 2000 1 2000
7. Hazard ratio in clinical trials. SL Spruance JE Reid M Grace M Samore, Antimicrob Agents Chemother 2004 48 8 2787 2792 10.1128/AAC.48.8.2787-2792.2004 15273082 (Pubitemid 38989137)
8. Determinants for HPV vaccine uptake in the Netherlands: A multilevel study. M Rondy A van Lier J van de Kassteele L Rust H de Melker, Vaccine 28 9 2070 2075
9. A Population-Based Evaluation of a Publicly Funded, School-Based HPV Vaccine Program in British Columbia, Canada: Parental Factors Associated with HPV Vaccine Receipt. G Ogilvie M Anderson F Marra S McNeil K Pielak M Dawar M McIvor T Ehlen S Dobson D Money D Patrick M Naus, Plos Medicine 7 5
10. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. L Brabin SA Roberts R Stretch D Baxter G Chambers H Kitchener R McCann, British Medical Journal 2008 336 7652 1056 1058 10.1136/bmj.39541.534109.BE 18436917 (Pubitemid 351692248)
11. Human Papillomavirus vaccination and social inequality: results from a prospective cohort study. SA Roberts L Brabin R Stretch D Baxter P Elton H Kitchener R McCann, Epidemiology and Infection 2011 139 3 400 405 10.1017/S095026881000066X 20334731
12. Adolescent immunization practices - A national survey of US physicians. SJ Schaffer SG Humiston LP Shone FM Averhoff PG Szilagyi, Archives of Pediatrics & Adolescent Medicine 2001 155 5 566 571 21199973 (Pubitemid 32405780)
13. Vaccine-preventable diseases: improving vaccination coverage in children, adolescents, and adults. A report on recommendations from the Task Force on Community Preventive Services. Centers for Disease Control and Prevention, Morbidity and Mortality Weekly Report 1999 1 15
14. Children's access to primary care: differences by race, income and insurance status. PW Newacheck DC Hughes JJ Stoddard, Pediatrics 1996 97 1 26 32 8545220 (Pubitemid 26012604)
15. Challenges to vaccinating adolescents - Vaccine implementation issues. SG Humiston SL Rosenthal, Pediatric Infectious Disease Journal 2005 24 6 134 S140 15931141 (Pubitemid 40840110)
16. Mass media interventions: effects on health services utilisation. R Grilli C Ramsay S Minozzi, Cochrane Database of Systematic Reviews 2002 1
17. Correlates for Human Papillomavirus Vaccination of Adolescent Girls and Young Women in a Managed Care Organization. C Chao C Velicer JM Slezak SJ Jacobsen, American Journal of Epidemiology 2010 171 3 357 367 10.1093/aje/kwp365 20047978
18. Predictors of time to completion of the hepatitis B vaccination series among adolescents. AB Middleman LM Robertson C Young RH Durant SJ Emans, J Adolesc Health 1999 25 5 323 327 10.1016/S1054-139X(99)00063-4 10551662 (Pubitemid 29495866)
19. Correlates of vaccination for hepatitis B among adolescents - Results front a parent survey. M Seid DR Simmes LS Linton CE Leah CC Edwards KM Peddecord, Archives of Pediatrics & Adolescent Medicine 2001 155 8 921 926 21199973 (Pubitemid 32729573)
20. Vaccination coverage in 14-year-old adolescents: Documentation, timeliness, and sociodemographic determinants. C Vandermeulen M Roelants H Theeten AM Depoorter P Van Damme K Hoppenbrouwers, Pediatrics 2008 121 3 428 E434 10.1542/peds.2007-1415 18310163
21. Determinants of universal adolescent hepatitis B vaccine uptake. LA Wallace JC Bramley S Ahmed R Duff SJ Hutchinson WF Carman NRE Kitchin DJ Goldberg, Archives of Disease in Childhood 2004 89 11 1041 1042 10.1136/adc.2003.043687 15499061
22. Factors associated with student participation in a school-based hepatitis B immunization program. ST Goldstein WM Cassidy W Hodgson FJ Mahoney, J Sch Health 2001 71 5 184 187 10.1111/j.1746-1561.2001.tb07313.x 11393930 (Pubitemid 33609874)
23. Socioeconomic differences in cancer incidence and mortality. F Faggiano T Partanen M Kogevinas P Boffetta, IARC Scientific Publications 1997 138
24. Social inequities along the cervical cancer continuum: a structured review. SJ Newmann EO Garner, Cancer Causes & Control 2005 16 1 63 70 10.1007/s10552-004-1290-y 21678481 (Pubitemid 40568852)
25. Studie van de vaccinatiegraad bij jonge kinderen en adolescenten in Vlaanderen in 2008. K Hoppenbrouwers C Vandermeulen M Roelants M Boonen P Van Damme H Theeten AM Depoorter, Vlaamse Overheid, Vlaams Agentschap Zorg en Gezondheid, Afdeling Toezicht Volksgezondheid, Team infectieziekten 2009
26. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. A Dempsey L Cohn V Dalton M Ruffin, Vaccine 2010 28 4 989 995 10.1016/j.vaccine. 2009.10.133 19925899
27. Factors that are associated with parental acceptability of Human Papillomavirus Vaccines: a randomized intervention study of written information about HPV. A Dempsey GD Zimet R Davis L Koutsky, Pediatrics 2006 117 5 1486 1493 10.1542/peds.2005-1381 16651301 (Pubitemid 46071374)
28. Effect of patient reminder/recall interventions on immunization rates - A review. PG Szilagyi C Bordley JC Vann A Chelminski RM Kraus PA Margolis LE Rodewald, JAMA - Journal of the American Medical Association 1998 284 14 1820 1827